The present disclosure encompasses methods and compositions for the use of stem cells for the treatment of inflammatory diseases, which include, but are not limited, to sepsis. The disclosure also relates to a micro-encapsulation system for immobilizing stem cells, methods for delivery of encapsulated stem cells to a subject with inflammation, and use of the encapsulated stem cells as therapy for acute and chronic infections.
